Your Input: | |||||
| ENSNMLP00000007824 | annotation not available (329 aa) | ||||
| ENSNMLP00000000002 | annotation not available (313 aa) | ||||
| ENSNMLP00000001581 | Eukaryotic translation initiation factor 2-alpha kinase 3. (1121 aa) | ||||
| ENSNMLP00000001634 | DNA fragmentation factor, alpha polypeptide. (308 aa) | ||||
| ENSNMLP00000001695 | Tubulin, alpha 1c. (459 aa) | ||||
| ENSNMLP00000001713 | annotation not available (227 aa) | ||||
| ENSNMLP00000001732 | V-fos FBJ murine osteosarcoma viral oncogene homolog Ab. (369 aa) | ||||
| ENSNMLP00000001978 | Ras-related associated with diabetes. (309 aa) | ||||
| ENSNMLP00000002220 | Lamin L3. (598 aa) | ||||
| ENSNMLP00000002777 | annotation not available (390 aa) | ||||
| ENSNMLP00000002818 | Activating transcription factor 4b. (377 aa) | ||||
| ENSNMLP00000002827 | Cathepsin K. (332 aa) | ||||
| ENSNMLP00000002869 | annotation not available (353 aa) | ||||
| ENSNMLP00000002881 | annotation not available (294 aa) | ||||
| ENSNMLP00000003756 | Calpain 1, (mu/I) large subunit a. (703 aa) | ||||
| TUBA1C | Tubulin alpha 1c. (451 aa) | ||||
| ENSNMLP00000004342 | annotation not available (178 aa) | ||||
| ENSNMLP00000004435 | annotation not available (329 aa) | ||||
| ENSNMLP00000004443 | Cathepsin S, ortholog 1. (331 aa) | ||||
| ENSNMLP00000004506 | annotation not available (695 aa) | ||||
| ENSNMLP00000004913 | Caspase 2, apoptosis-related cysteine peptidase. (453 aa) | ||||
| ENSNMLP00000005095 | annotation not available (559 aa) | ||||
| ENSNMLP00000005116 | annotation not available (179 aa) | ||||
| ENSNMLP00000005123 | annotation not available (119 aa) | ||||
| ENSNMLP00000005318 | annotation not available (136 aa) | ||||
| ENSNMLP00000006159 | Caspase 9, apoptosis-related cysteine peptidase. (439 aa) | ||||
| ENSNMLP00000006473 | V-akt murine thymoma viral oncogene homolog 3a. (499 aa) | ||||
| ENSNMLP00000006609 | annotation not available (102 aa) | ||||
| ENSNMLP00000006840 | Phosphoinositide-3-kinase, regulatory subunit 2 (beta). (705 aa) | ||||
| ENSNMLP00000006899 | Inositol 1,4,5-trisphosphate receptor, type 2. (2643 aa) | ||||
| KRAS | KRAS proto-oncogene, GTPase. (189 aa) | ||||
| ENSNMLP00000007215 | BCL2 like 1. (196 aa) | ||||
| ENSNMLP00000007216 | annotation not available (202 aa) | ||||
| ENSNMLP00000007226 | annotation not available (112 aa) | ||||
| ENSNMLP00000007286 | annotation not available (334 aa) | ||||
| ENSNMLP00000007302 | Cathepsin Bb. (226 aa) | ||||
| ENSNMLP00000007476 | annotation not available (416 aa) | ||||
| CSDE1 | Cold shock domain containing E1. (906 aa) | ||||
| ENSNMLP00000007580 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha b. (313 aa) | ||||
| ENSNMLP00000007648 | annotation not available (332 aa) | ||||
| ENSNMLP00000007715 | annotation not available (239 aa) | ||||
| ENSNMLP00000007968 | V-akt murine thymoma viral oncogene homolog 3b. (502 aa) | ||||
| ENSNMLP00000007992 | annotation not available (232 aa) | ||||
| ENSNMLP00000008250 | Tnf receptor-associated factor 2a. (510 aa) | ||||
| ENSNMLP00000008533 | Tnf receptor-associated factor 2b. (524 aa) | ||||
| ENSNMLP00000008623 | Inhibitor of nuclear factor kappa B kinase subunit beta. (741 aa) | ||||
| ENSNMLP00000008711 | HtrA serine peptidase 4. (431 aa) | ||||
| ENSNMLP00000009117 | annotation not available (283 aa) | ||||
| ENSNMLP00000009343 | Septin 4a. (397 aa) | ||||
| ENSNMLP00000009376 | CD40 ligand. (238 aa) | ||||
| ENSNMLP00000010864 | Perforin 1.5. (501 aa) | ||||
| ENSNMLP00000011465 | annotation not available (435 aa) | ||||
| ENSNMLP00000011509 | Cathepsin F. (471 aa) | ||||
| ENSNMLP00000011877 | annotation not available (235 aa) | ||||
| ENSNMLP00000011899 | annotation not available (333 aa) | ||||
| ENSNMLP00000011945 | MCL1 apoptosis regulator, BCL2 family member b. (273 aa) | ||||
| ENSNMLP00000011957 | Mitogen-activated protein kinase kinase 2a. (401 aa) | ||||
| ENSNMLP00000011996 | Caspase 3, apoptosis-related cysteine peptidase a. (271 aa) | ||||
| ENSNMLP00000012118 | Poly (ADP-ribose) polymerase 2. (633 aa) | ||||
| ENSNMLP00000012604 | Baculoviral IAP repeat containing 5b. (147 aa) | ||||
| ENSNMLP00000012796 | HtrA serine peptidase 1a. (480 aa) | ||||
| ENSNMLP00000013258 | annotation not available (396 aa) | ||||
| ENSNMLP00000013389 | annotation not available (1061 aa) | ||||
| ENSNMLP00000013604 | annotation not available (232 aa) | ||||
| ENSNMLP00000014097 | Actin, beta 2. (377 aa) | ||||
| ENSNMLP00000014598 | V-akt murine thymoma viral oncogene homolog 2. (482 aa) | ||||
| ENSNMLP00000014811 | Nerve growth factor a (beta polypeptide). (244 aa) | ||||
| ENSNMLP00000015163 | V-fos FBJ murine osteosarcoma viral oncogene homolog Aa. (425 aa) | ||||
| ENSNMLP00000015253 | Zgc:153993. (181 aa) | ||||
| HRAS | HRas proto-oncogene, GTPase. (189 aa) | ||||
| ENSNMLP00000015574 | Nerve growth factor b (beta polypeptide). (188 aa) | ||||
| ENSNMLP00000016092 | Perforin 1.2. (573 aa) | ||||
| ENSNMLP00000016229 | Jun proto-oncogene, AP-1 transcription factor subunit. (325 aa) | ||||
| ENSNMLP00000016334 | annotation not available (605 aa) | ||||
| ENSNMLP00000016592 | annotation not available (104 aa) | ||||
| ENSNMLP00000016736 | DNA-damage-inducible transcript 3. (284 aa) | ||||
| ENSNMLP00000016926 | Baculoviral IAP repeat containing 2. (618 aa) | ||||
| GADD45B | Growth arrest and DNA damage inducible beta. (165 aa) | ||||
| ENSNMLP00000017568 | annotation not available (266 aa) | ||||
| ENSNMLP00000017869 | annotation not available (740 aa) | ||||
| ENSNMLP00000017875 | annotation not available (179 aa) | ||||
| ENSNMLP00000017987 | Tubulin, alpha 8 like 2. (302 aa) | ||||
| ENSNMLP00000017993 | annotation not available (453 aa) | ||||
| ENSNMLP00000018315 | Tubulin, alpha 8 like 3. (536 aa) | ||||
| ENSNMLP00000019256 | Growth arrest and DNA-damage-inducible, alpha, a. (190 aa) | ||||
| ENSNMLP00000019907 | annotation not available (367 aa) | ||||
| ENSNMLP00000019909 | annotation not available (377 aa) | ||||
| ENSNMLP00000019912 | annotation not available (324 aa) | ||||
| ENSNMLP00000020228 | annotation not available (337 aa) | ||||
| ENSNMLP00000020427 | Lamin B1. (581 aa) | ||||
| ENSNMLP00000020665 | Diablo, IAP-binding mitochondrial protein a. (248 aa) | ||||
| ENSNMLP00000021130 | annotation not available (867 aa) | ||||
| ENSNMLP00000021213 | annotation not available (105 aa) | ||||
| ENSNMLP00000021255 | Endoplasmic reticulum to nucleus signaling 1. (1080 aa) | ||||
| ENSNMLP00000021361 | Caspase 10, apoptosis-related cysteine peptidase. (523 aa) | ||||
| ENSNMLP00000021375 | Poly (ADP-ribose) polymerase family, member 4. (1354 aa) | ||||
| ENSNMLP00000021935 | Tumor protein p53. (352 aa) | ||||
| ENSNMLP00000022030 | Mitogen-activated protein kinase 3. (394 aa) | ||||
| ENSNMLP00000022127 | Baculoviral IAP repeat containing 5a. (142 aa) | ||||
| ENSNMLP00000022184 | Cathepsin 12. (370 aa) | ||||
| ENSNMLP00000022230 | DAB2 interacting protein b. (1129 aa) | ||||
| ENSNMLP00000022308 | annotation not available (361 aa) | ||||
| ENSNMLP00000022495 | Growth arrest and DNA-damage-inducible, gamma b, tandem duplicate 1. (144 aa) | ||||
| ENSNMLP00000022497 | annotation not available (158 aa) | ||||
| CHUK | Component of inhibitor of nuclear factor kappa B kinase complex. (762 aa) | ||||
| ENSNMLP00000022765 | annotation not available (152 aa) | ||||
| ENSNMLP00000022926 | Caspase 6, apoptosis-related cysteine peptidase a. (330 aa) | ||||
| ENSNMLP00000023214 | Calpain 9. (683 aa) | ||||
| ENSNMLP00000023238 | Mitogen-activated protein kinase 8b. (451 aa) | ||||
| ENSNMLP00000023329 | Apoptosis inducing factor mitochondrion associated 1. (723 aa) | ||||
| ENSNMLP00000023570 | Mitogen-activated protein kinase kinase kinase 5. (1315 aa) | ||||
| ENSNMLP00000023697 | annotation not available (246 aa) | ||||
| ENSNMLP00000023758 | annotation not available (480 aa) | ||||
| ENSNMLP00000024528 | annotation not available (433 aa) | ||||
| ENSNMLP00000024613 | annotation not available (253 aa) | ||||
| ENSNMLP00000024666 | X-linked inhibitor of apoptosis. (476 aa) | ||||
| ENSNMLP00000024676 | annotation not available (212 aa) | ||||
| ENSNMLP00000024873 | Caspase 7, apoptosis-related cysteine peptidase. (319 aa) | ||||
| ENSNMLP00000024882 | TNF superfamily member 10. (273 aa) | ||||
| ENSNMLP00000024928 | annotation not available (289 aa) | ||||
| ENSNMLP00000025064 | annotation not available (303 aa) | ||||
| ENSNMLP00000025084 | annotation not available (203 aa) | ||||
| ENSNMLP00000026118 | Mitogen-activated protein kinase 8a. (467 aa) | ||||
| ENSNMLP00000026503 | Calpain 3a, (p94). (497 aa) | ||||
| ENSNMLP00000026790 | annotation not available (454 aa) | ||||
| ENSNMLP00000027024 | Si:dkey-33c12.12. (435 aa) | ||||
| ENSNMLP00000027230 | annotation not available (203 aa) | ||||
| ENSNMLP00000027252 | Protein phosphatase 1, regulatory (inhibitor) subunit 14Ba. (152 aa) | ||||
| ENSNMLP00000027304 | Cathepsin C. (457 aa) | ||||
| ENSNMLP00000029025 | annotation not available (375 aa) | ||||
| ENSNMLP00000029492 | annotation not available (936 aa) | ||||
| ENSNMLP00000029516 | Endonuclease G. (276 aa) | ||||
| ENSNMLP00000029916 | annotation not available (420 aa) | ||||
| ENSNMLP00000029953 | Poly (ADP-ribose) polymerase family, member 3. (459 aa) | ||||
| ENSNMLP00000030089 | V-rel avian reticuloendotheliosis viral oncogene homolog A. (603 aa) | ||||
| ENSNMLP00000030363 | annotation not available (364 aa) | ||||
| ENSNMLP00000030668 | Cathepsin L.1. (317 aa) | ||||
| ENSNMLP00000030669 | Cathepsin L.1. (356 aa) | ||||
| ENSNMLP00000030928 | Phosphoinositide-3-kinase, regulatory subunit 3a (gamma). (467 aa) | ||||
| ENSNMLP00000031444 | Septin 5b. (368 aa) | ||||
| ENSNMLP00000031769 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha a. (310 aa) | ||||
| ENSNMLP00000032097 | DNA fragmentation factor, beta polypeptide (caspase-activated DNase). (330 aa) | ||||
| ENSNMLP00000032713 | annotation not available (232 aa) | ||||
| ENSNMLP00000032993 | Death-domain associated protein. (635 aa) | ||||
| ENSNMLP00000033154 | BCL2 associated agonist of cell death b. (148 aa) | ||||
| ENSNMLP00000033334 | annotation not available (290 aa) | ||||
| ENSNMLP00000033465 | annotation not available (452 aa) | ||||
| ENSNMLP00000034002 | Apoptotic peptidase activating factor 1. (1256 aa) | ||||
| ENSNMLP00000034264 | Tumor necrosis factor receptor superfamily, member a. (446 aa) | ||||
| ENSNMLP00000034676 | annotation not available (165 aa) | ||||
| ENSNMLP00000034768 | Neurotrophic tyrosine kinase, receptor, type 1. (790 aa) | ||||
| ENSNMLP00000034807 | Tumor necrosis factor receptor superfamily, member 1a. (362 aa) | ||||
| ENSNMLP00000034816 | HtrA serine peptidase 1b. (476 aa) | ||||
| ENSNMLP00000035221 | annotation not available (481 aa) | ||||
| ENSNMLP00000035323 | Tnfrsf1a-associated via death domain. (296 aa) | ||||
| ENSNMLP00000035380 | annotation not available (96 aa) | ||||
| ENSNMLP00000035406 | annotation not available (379 aa) | ||||
| ENSNMLP00000035595 | 3-phosphoinositide dependent protein kinase 1b. (531 aa) | ||||
| ENSNMLP00000035660 | Calpain 3b. (565 aa) | ||||
| ENSNMLP00000035951 | Zgc:55558. (191 aa) | ||||
| ENSNMLP00000036502 | V-akt murine thymoma viral oncogene homolog 1. (475 aa) | ||||
| ENSNMLP00000037216 | BCL2 apoptosis regulator b. (210 aa) | ||||
| ENSNMLP00000037512 | annotation not available (607 aa) | ||||
| ENSNMLP00000037787 | annotation not available (179 aa) | ||||
| ENSNMLP00000038157 | annotation not available (201 aa) | ||||
| ENSNMLP00000038183 | annotation not available (638 aa) | ||||
| ENSNMLP00000038184 | annotation not available (89 aa) | ||||
| ENSNMLP00000038186 | annotation not available (120 aa) | ||||
| ENSNMLP00000038286 | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta. (1042 aa) | ||||
| ENSNMLP00000038512 | annotation not available (555 aa) | ||||
| ENSNMLP00000038659 | Growth arrest and DNA-damage-inducible, gamma a. (159 aa) | ||||
| ENSNMLP00000038936 | annotation not available (581 aa) | ||||
| ENSNMLP00000039105 | annotation not available (588 aa) | ||||
| ENSNMLP00000039206 | Mitogen-activated protein kinase 1. (399 aa) | ||||
| ENSNMLP00000039233 | annotation not available (593 aa) | ||||
| ENSNMLP00000039389 | annotation not available (206 aa) | ||||
| ENSNMLP00000039404 | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta. (1023 aa) | ||||
| GADD45B-2 | Growth arrest and DNA damage inducible beta. (158 aa) | ||||
| ENSNMLP00000039578 | annotation not available (170 aa) | ||||
| ENSNMLP00000040066 | HPS5 biogenesis of lysosomal organelles complex 2 subunit 2. (1090 aa) | ||||
| LMNA | Lamin A/C. (664 aa) | ||||
| ENSNMLP00000040158 | Si:ch211-1i11.3. (1184 aa) | ||||
| ENSNMLP00000040624 | Cathepsin Z. (271 aa) | ||||
| ENSNMLP00000040782 | annotation not available (480 aa) | ||||
| ENSNMLP00000041074 | BCL2 associated X, apoptosis regulator a. (140 aa) | ||||
| ENSNMLP00000041075 | Mitogen-activated protein kinase kinase kinase 14a. (787 aa) | ||||
| ENSNMLP00000041939 | Mitogen-activated protein kinase 9. (477 aa) | ||||
| ENSNMLP00000042724 | Cathepsin Ba. (330 aa) | ||||
| ENSNMLP00000042820 | Receptor (TNFRSF)-interacting serine-threonine kinase 1, like. (665 aa) | ||||
| ENSNMLP00000043142 | Cathepsin D. (440 aa) | ||||
| ENSNMLP00000043305 | annotation not available (295 aa) | ||||
| ENSNMLP00000043326 | Phosphoinositide-3-kinase, regulatory subunit 1 (alpha). (727 aa) | ||||
| ENSNMLP00000043347 | Un-named sa808. (595 aa) | ||||
| ENSNMLP00000043391 | Zgc:55262. (688 aa) | ||||
| ENSNMLP00000043529 | annotation not available (402 aa) | ||||
| ENSNMLP00000043781 | Granzyme 3, tandem duplicate 3. (211 aa) | ||||
| ENSNMLP00000043945 | annotation not available (189 aa) | ||||
| ENSNMLP00000044088 | annotation not available (464 aa) | ||||
| ENSNMLP00000044260 | GTP binding protein overexpressed in skeletal muscle. (295 aa) | ||||
| ENSNMLP00000044398 | Eukaryotic translation initiation factor 2, subunit 1 alpha b. (312 aa) | ||||
| ENSNMLP00000045077 | annotation not available (924 aa) | ||||